These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38270729)

  • 1. Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy.
    Tan SY; Tan CY; Yahya MA; Low SC; Shahrizaila N; Goh KJ
    Neurol Sci; 2024 Jul; 45(7):3449-3459. PubMed ID: 38270729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study.
    Vegezzi E; Cortese A; Bergsland N; Mussinelli R; Paoletti M; Solazzo F; Currò R; Ascagni L; Callegari I; Quartesan I; Lozza A; Deligianni X; Santini F; Marchioni E; Cosentino G; Alfonsi E; Tassorelli C; Bastianello S; Merlini G; Palladini G; Obici L; Pichiecchio A
    J Neurol; 2023 Jan; 270(1):328-339. PubMed ID: 36064814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.
    Gasparotti R; Salvalaggio A; Corbo D; Agazzi G; Cacciavillani M; Lozza A; Fenu S; De Vigili G; Tagliapietra M; Fabrizi GM; Pareyson D; Obici L; Briani C
    J Neurol; 2023 Oct; 270(10):4827-4840. PubMed ID: 37329346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
    Kollmer J; Hegenbart U; Kimmich C; Hund E; Purrucker JC; Hayes JM; Lentz SI; Sam G; Jende JME; Schönland SO; Bendszus M; Heiland S; Weiler M
    Ann Clin Transl Neurol; 2020 May; 7(5):799-807. PubMed ID: 32333729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy.
    Hodel J; Benadjaoud S; Benadjaoud MA; Lefaucheur JP; Planté-Bordeneuve V
    Eur Radiol; 2022 Nov; 32(11):7865-7871. PubMed ID: 35438324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
    Merkel M; Danese D; Chen C; Wang J; Wu A; Yang H; Lin H
    Expert Opin Pharmacother; 2023; 24(10):1205-1214. PubMed ID: 37219406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).
    Galosi E; Costanzo R; Forcina F; Morino S; Antonini G; Salvetti M; Lauletta A; Luigetti M; Romano A; Primiano G; Guglielmino V; Fionda L; Garibaldi M; Esposito N; Falco P; di Pietro G; Truini A; Leonardi L
    Neurol Sci; 2024 Oct; 45(10):5023-5032. PubMed ID: 38700599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.
    Leonardi L; Di Pietro G; Di Pasquale A; Vanoli F; Fionda L; Garibaldi M; Galosi E; Alfieri G; Lauletta A; Morino S; Salvetti M; Truini A; Antonini G
    Neurol Sci; 2022 May; 43(5):3387-3394. PubMed ID: 34802089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
    Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
    J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease.
    Poncelet A; Weiler M; Hegenbart U; Sam G; Schönland S; Purrucker JC; Hayes JM; Hund E; Bendszus M; Heiland S; Kollmer J
    Invest Radiol; 2022 May; 57(5):301-307. PubMed ID: 34839307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study.
    Primiano G; Verdolotti T; D'Apolito G; Di Paolantonio A; Guglielmino V; Romano A; Lucioli G; Luigetti M; Servidei S
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.
    Salvalaggio A; Coraci D; Cacciavillani M; Obici L; Mazzeo A; Luigetti M; Pastorelli F; Grandis M; Cavallaro T; Bisogni G; Lozza A; Gemelli C; Gentile L; Ermani M; Fabrizi GM; Plasmati R; Campagnolo M; Castellani F; Gasparotti R; Martinoli C; Padua L; Briani C
    J Neurol; 2021 Jan; 268(1):189-198. PubMed ID: 32749600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis.
    Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S
    Clin Neurophysiol; 2024 Mar; 159():81-95. PubMed ID: 38377648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
    Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
    Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
    Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
    Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
    Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Kessler L; Rischpler C; Malik RA; Herrmann K; Reinhardt HC; Rassaf T; Kleinschnitz C; Hagenacker T; Stettner M
    J Neurol; 2023 Jul; 270(7):3483-3491. PubMed ID: 37014422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.
    Salvalaggio A; Coraci D; Obici L; Cacciavillani M; Luigetti M; Mazzeo A; Pastorelli F; Grandis M; Cavallaro T; Bisogni G; Lozza A; Gemelli C; Gentile L; Russo M; Ermani M; Fabrizi GM; Plasmati R; De Napoli F; Campagnolo M; Castellani F; Salvi F; Fenu S; Devigili G; Pareyson D; Gasparotti R; Rapezzi C; Martinoli C; Padua L; Briani C
    J Neurol; 2022 Apr; 269(4):1905-1912. PubMed ID: 34410494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.
    Leonardi L; Adam C; Beaudonnet G; Beauvais D; Cauquil C; Not A; Morassi O; Benmalek A; Trassard O; Echaniz-Laguna A; Adams D; Labeyrie C
    Eur J Neurol; 2022 May; 29(5):1477-1487. PubMed ID: 35100482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.